Drug intelligence / Profile preview

GHB1589M

Development stage
Preclinical
Lead developer
Gatehouse Bio
Modality
MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Inhalation
01

Overview

GHB1589M is a preclinical inhaled oligonucleotide therapeutic being developed by Gatehouse Bio for the treatment of idiopathic pulmonary fibrosis (IPF). Discovered using the company's AI-driven Code-Breaker™ platform, which identifies disease-driving small RNA (sRNA) isoforms, the drug is designed to target specific molecular mechanisms underlying lung fibrosis. By utilizing an inhaled delivery method, GHB1589M aims to provide direct therapeutic action within the lung tissue while minimizing systemic exposure.

Beyond the preview

Go deeper on GHB1589M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GHB1589M.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call